28 | 08 | 2024
MATTHIAS WAGNER
Co-Founder & CTO

AI: Scaling Therapies to More Humans

+

The discussion around “Can AI accelerate biotech?” is invariably dominated by the debate over whether/when AI will revolutionize drug discovery. The conversation often resembles the one over whether/when AGI will emerge, with fervent camps dug into their positions. So it is not unusual to hear extreme statements to the effect of “AI will never work […]

30 | 10 | 2023
MARINNA MADRID, PhD
Co-Founder & Chief Product Officer

Democratizing Personalized Regenerative Medicine

+

As National Hispanic Heritage Month has recently concluded, I am reflecting on the Hispanic Health Summit, hosted by the U.S. Department of Health and Human Services as part of its National Hispanic Heritage Month event series. Secretary Xavier Becerra highlighted the need for collective action to improve equity and access to health care in the […]

20 | 07 | 2023
WILLIE REAVES
Head of Public Engagement

ARPA-H Dash: Building Toward Your Cells, Your Cure™

+

This past spring, Cellino had the opportunity to participate in the ARPA-H Dash to Accelerate Health Outcomes, a national competition designed to crowdsource groundbreaking concepts that improve health for everyone. The Dash was hosted by the Advanced Research Projects Agency for Health (ARPA-H), a recently formed government agency dedicated to accelerating transformative health solutions that […]

30 | 06 | 2023
NABIHA SAKLAYEN, PhD
Co-founder & CEO

A Golden Week For Cell Therapies

+

Cell therapies offer the promise of reversing and even curing the most debilitating diseases, including diabetes and Parkinson’s. The long-awaited moment has arrived, and this week we witnessed a surge of positive patient data that the regenerative medicine community has eagerly awaited. The infectious positive energy at the Cellino office in Kendall Square grew with each […]

In November 2022, the Cellino leadership team was invited to participate in a White House Listening Session on “Harnessing Biotechnology and Biomanufacturing for Health Breakthroughs,” hosted by the Biden Administration’s Office of Science and Technology Policy. We were among a small group of industry and academic thought leaders asked to share our perspectives on specific […]

16 | 03 | 2022
NABIHA SAKLAYEN, PHD, & BROOKE BARRETTSMITH, MED

Always Growing in Emotional Intelligence

+

The past year highlighted a major strength of the Cellino team: the ability to remain well-aligned across technically diverse streams of work. The three key ingredients that make the Cellino team shine are growth mindset, emotional intelligence, and low ego. In this post, we (Nabiha Saklayen, CEO & Co-Founder and Brooke Barrettsmith, Head of Transformative Leadership) […]

Cell-based therapies present enormous opportunities to improve the lives of patients suffering from a number of diseases. One example is CAR T-cell therapies, which re-engineer a patient’s immune cells, and have shown impressive response rates in certain blood cancers. But there is a tremendous unmet demand for personalized cell therapies to treat degenerative diseases — diseases in […]

14 | 01 | 2021
NABIHA SAKLAYEN, PhD
Co-founder & CEO

Every Human. Every Cell.

+

There are 7.8 billion humans on the planet today. No matter where we call home, every one of us contains the same building blocks, cells. Ten trillion cells in the human body work in synchronicity to pump blood, produce insulin, secrete dopamine, and see the world around us. What happens if cells go awry and stop doing their […]